Bausch Health Companies (BHC) 8-K Results of Operations and Financial Condition

Update on Bausch + Lomb Q2 Performance

(1)

•

Consumer

•

RX Pharma

•

Surgical

•

Contact Lens

•

Generics

Emerging Markets

Other Developed Markets

Organic Growth:

Q2 2014/Q2 2013

22

14%

8%

14%

United States

12%

17%

12%

38%

3%

Country/Region

Notes

(1)

Total

12%

~90% of growth in the U.S. was from volume

Preliminary Estimates

>90% of the growth on a global basis was from volume

Exhibit 99.2

Bausch + Lomb Performance Acquisition through Q2

2014

(1)

•

Consumer

•

RX Pharma

•

Surgical

•

Contact Lens

•

Generics

Emerging Markets

Other Developed Markets

Organic Growth

since acquisition

23

13%

10%

13%

United States

12%

11%

11%

12%

29%

Country/Region

Notes

(1)

Total

11%

~90% of growth in the U.S. was from volume

Preliminary Estimates

>90% of the growth on a global basis was from volume